Today: 21 May 2026
Verizon stock price jumps after earnings as $25 billion buyback lifts VZ in late trading
30 January 2026
2 mins read

Verizon stock price jumps after earnings as $25 billion buyback lifts VZ in late trading

New York, Jan 30, 2026, 17:27 ET — After-hours

  • Verizon shares jumped almost 12% following the carrier’s report of a sharp rise in quarterly subscriber additions and the announcement of a new buyback program.
  • The company expects adjusted EPS in 2026 to land between $4.90 and $4.95, with free cash flow projected at a minimum of $21.5 billion.
  • Verizon’s board upped its quarterly dividend and forecasted share buybacks of at least $3 billion in 2026.

Verizon Communications Inc. shares jumped 11.8% to $44.52 in after-hours trading on Friday, bouncing between $39.70 and $44.63 throughout the session.

This shift is significant since U.S. wireless now revolves around bundles and discounts, with investors zeroing in on churn and cash just as much as growth. A carrier reporting strong “postpaid” adds — customers who pay monthly bills — can quickly shift sentiment.

Verizon reported adding 616,000 postpaid phone subscribers in the fourth quarter, surpassing expectations, fueled by holiday promotions. One deal offered four phone lines for $100 a month. Analysts at MoffettNathanson noted Verizon’s fiber network is now “almost the size of” AT&T’s following its Frontier Communications acquisition. Reuters

Verizon reported adjusted earnings of $1.09 per share for the fourth quarter on $36.4 billion in revenue. The company added 372,000 broadband subscribers, including 319,000 from fixed wireless access. It projects retail postpaid phone net additions between 750,000 and 1 million for 2026. Free cash flow for 2026 is expected to reach $21.5 billion or more, with capital expenditures forecasted at $16.0 billion to $16.5 billion. CEO Dan Schulman declared, “Verizon will no longer be a hunting ground for our competitors.” SEC

Verizon’s board greenlit a share buyback program of up to $25 billion, with plans to repurchase at least $3 billion in stock during 2026, according to a regulatory filing. The company also announced a quarterly dividend of $0.7075 per share, payable May 1 to shareholders of record April 10. Verizon aims to return roughly $55 billion to shareholders by the end of 2028 through dividends and buybacks.

Investors are focused on whether Verizon can keep growing its subscriber base without relying heavily on discounts. Management expects wireless service revenue to remain roughly flat as it aims for “healthy volumes,” walking a fine line in a market sensitive to pricing.

Competition is fierce. Verizon is pushing to bundle mobile service with home broadband—both fiber and fixed wireless—to hold onto customers amid pressure from T-Mobile US and other challengers.

Risks cut both ways. Larger promotions could tighten margins, while integration efforts from the Frontier deal might drive up execution expenses. The buyback remains discretionary—Verizon noted timing hinges on prices and market conditions, and repurchases can be paused.

Verizon announced it updated and modernized a long-term MVNO agreement — a wholesale arrangement where another company resells wireless service — with Charter Communications and Comcast. This move preserves a valuable channel with cable operators who have been ramping up their wireless efforts.

The key question now: will Friday’s surge stick when U.S. markets open Monday, Feb. 2? Verizon plans to pay its $0.69 quarterly dividend that day, which should keep income-focused investors engaged. Traders will be eyeing early-2026 churn and watching closely for any evidence that the buyback program has kicked off.

Stock Market Today

  • EnerSys Q1 CY2026 Sales Beat Estimates with Optimistic Guidance
    May 20, 2026, 6:18 PM EDT. Battery maker EnerSys (NYSE:ENS) reported Q1 CY2026 sales of $988 million, up 1.4% year on year, beating analyst estimates by 1.5%. Adjusted earnings per share (EPS) stood at $3.19, a 6.6% beat over consensus. Guidance for Q2 revenue is $935 million, 2.2% above estimates, with adjusted EPS guidance also exceeding forecasts. Despite a 6% decline in sales volumes, revenue growth was supported by price increases. Free cash flow turned negative at -$12.66 million, down from $105 million last year. EnerSys continues to push its lithium data center and battery energy storage system solutions, signaling long-term innovation. The company's subdued 4.7% annualized revenue growth over five years contrasts with sector expectations, raising caution among investors.

Latest articles

Silexion Stock Almost Doubles: Cancer Trial Push, Cash Questions and Nasdaq Risk Drive SLXN Frenzy

Silexion Stock Almost Doubles: Cancer Trial Push, Cash Questions and Nasdaq Risk Drive SLXN Frenzy

21 May 2026
New York, May 20, 2026, 18:02 (EDT) Silexion Therapeutics Corp’s Nasdaq-listed shares nearly doubled on Wednesday, closing at $0.5298, up 96.95%, before slipping 9.5% in after-hours trading as the low-priced oncology stock drew more than 325 million shares in volume. The stock had ended Tuesday at $0.269. The move came after regular trading had ended in New York. Nasdaq’s normal session runs from 9:30 a.m. to 4:00 p.m. Eastern time, with after-hours trading available from 4:00 p.m. to 8:00 p.m.; May 20 was not a U.S. exchange holiday. The reason it matters now is simple enough: Silexion is trying to
AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

21 May 2026
AEVEX Corp. shares surged over 10% after hours Wednesday following a first-quarter profit of $21 million and new U.S. Air Force contracts worth $15.6 million. Revenue jumped to $216.7 million, beating estimates. The company, which went public in April, raised its full-year revenue outlook to $600–$620 million. The stock had closed regular trading at $26.27, down 0.23%.
Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

21 May 2026
Jupiter Neurosciences shares fell 37% to $0.205 Wednesday after announcing a proposed U.S. licensing deal for PharmAla Biotech’s MDMA-based ALA-002 and a $2 million stock offering. Trading volume topped 230 million shares. The licensing agreement is non-binding, with a potential value over $100 million, and gives Jupiter 90 days to finalize terms. Jupiter reported a $2.06 million Q1 net loss and $2.36 million in cash.
Oracle stock price drops again as AI fears weigh; Air Force cloud order lands
Previous Story

Oracle stock price drops again as AI fears weigh; Air Force cloud order lands

Eli Lilly stock climbs after $3.5 billion Pennsylvania plant plan as traders eye Feb. 4 results
Next Story

Eli Lilly stock climbs after $3.5 billion Pennsylvania plant plan as traders eye Feb. 4 results

Go toTop